Circulating MiRNAs as diagnostic biomarkers of lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis
Abstract Managing lupus nephritis (LN) has been challenging despite therapeutic advancements, as 30% of patients face end-stage kidney disease. Current laboratory tests for diagnosing LN activity are insufficient. Recognizing the potential for severe complications in patients with LN, there is cruci...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-07860-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849335319354146816 |
|---|---|
| author | Ermiyas Alemayehu Alemu Gedefie Habtu Debash Abebaw Worede Zewudu Mulatie Endris Ebrahim Mulugeta Teshome Hussen Ebrahim Melaku Ashagrie Belete |
| author_facet | Ermiyas Alemayehu Alemu Gedefie Habtu Debash Abebaw Worede Zewudu Mulatie Endris Ebrahim Mulugeta Teshome Hussen Ebrahim Melaku Ashagrie Belete |
| author_sort | Ermiyas Alemayehu |
| collection | DOAJ |
| description | Abstract Managing lupus nephritis (LN) has been challenging despite therapeutic advancements, as 30% of patients face end-stage kidney disease. Current laboratory tests for diagnosing LN activity are insufficient. Recognizing the potential for severe complications in patients with LN, there is crucial need to identify innovative biomarkers for early diagnosis of this disease. Hence, the objective of this study was to evaluate diagnostic efficacy of miRNAs for LN. The protocol has been registered on PROSPERO (CRD42023460747). This systematic review and meta-analysis was performed following the PRISMA guidelines. A comprehensive search for relevant literature was carried out across PubMed, Scopus, Embase, and Hinari. The methodological quality of the articles was assessed using the QUADAS-2 tool. Stata 14.0 software was used to calculate pooled sensitivity, specificity, and other diagnostic parameters related to miRNAs for the diagnosis of LN utilizing a random effects model. The assessment of heterogeneity among studies involved the application of the Cochran-Q test and I2 statistic tests. Subsequently, subgroup analyses and meta-regression analysis were conducted to investigate the primary sources of heterogeneity. To evaluate publication bias, Deeks’ funnel plot was used. Additionally, Fagan’s nomogram and likelihood ratio scattergram were used to assess the clinical utility of miRNAs for LN. Additionally, a sensitivity analysis was conducted to evaluate the robustness and reliability of the results. In this meta-analysis, 23 studies from 11 publications were included, encompassing a total of 526 LN patients and 490 controls. The selected studies pertained low risk of bias. The overall pooled values for sensitivity, specificity, PLR, NLR, DOR, and AUC were 0.85 (95% CI 0.78–0.89), 0.83 (95% CI 0.75–0.89), 4.93 (95% CI 3.47–7.07), 0.19 (95% CI 0.13–0.26), 26.35 (95% CI 16.39–42.36), and 0.91 (95% CI 0.88–0.93), respectively. Furthermore, miR-181a, miR-223 and miR-146a demonstrated superior diagnostic efficacy with promising clinical utility in excluding and confirming LN. Additionally, findings from the subgroup analysis indicated that miRNA panels, upregulated miRNAs, and miRNAs used in the diagnosis of African patients exhibited superior diagnostic performance. Circulating microRNAs (miRNAs) show promise as noninvasive biomarkers for the early diagnosis of LN. Furthermore, miRNA panels and upregulated miRNAs exhibited improved diagnostic efficacy for LN diagnosis. However, substantiating these findings will necessitate a substantial number of prospective studies and multicenter studies in the near future. |
| format | Article |
| id | doaj-art-db9ec343c08c40e0804ce6b25afb1ffd |
| institution | Kabale University |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-db9ec343c08c40e0804ce6b25afb1ffd2025-08-20T03:45:19ZengNature PortfolioScientific Reports2045-23222025-07-0115111410.1038/s41598-025-07860-3Circulating MiRNAs as diagnostic biomarkers of lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysisErmiyas Alemayehu0Alemu Gedefie1Habtu Debash2Abebaw Worede3Zewudu Mulatie4Endris Ebrahim5Mulugeta Teshome6Hussen Ebrahim7Melaku Ashagrie Belete8Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo UniversityDepartment of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo UniversityDepartment of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo UniversityDepartment of Clinical Chemistry, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of GondarDepartment of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo UniversityDepartment of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo UniversityDepartment of Medical Laboratory, Dessie Comprehensive Specialized HospitalDepartment of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo UniversityDepartment of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo UniversityAbstract Managing lupus nephritis (LN) has been challenging despite therapeutic advancements, as 30% of patients face end-stage kidney disease. Current laboratory tests for diagnosing LN activity are insufficient. Recognizing the potential for severe complications in patients with LN, there is crucial need to identify innovative biomarkers for early diagnosis of this disease. Hence, the objective of this study was to evaluate diagnostic efficacy of miRNAs for LN. The protocol has been registered on PROSPERO (CRD42023460747). This systematic review and meta-analysis was performed following the PRISMA guidelines. A comprehensive search for relevant literature was carried out across PubMed, Scopus, Embase, and Hinari. The methodological quality of the articles was assessed using the QUADAS-2 tool. Stata 14.0 software was used to calculate pooled sensitivity, specificity, and other diagnostic parameters related to miRNAs for the diagnosis of LN utilizing a random effects model. The assessment of heterogeneity among studies involved the application of the Cochran-Q test and I2 statistic tests. Subsequently, subgroup analyses and meta-regression analysis were conducted to investigate the primary sources of heterogeneity. To evaluate publication bias, Deeks’ funnel plot was used. Additionally, Fagan’s nomogram and likelihood ratio scattergram were used to assess the clinical utility of miRNAs for LN. Additionally, a sensitivity analysis was conducted to evaluate the robustness and reliability of the results. In this meta-analysis, 23 studies from 11 publications were included, encompassing a total of 526 LN patients and 490 controls. The selected studies pertained low risk of bias. The overall pooled values for sensitivity, specificity, PLR, NLR, DOR, and AUC were 0.85 (95% CI 0.78–0.89), 0.83 (95% CI 0.75–0.89), 4.93 (95% CI 3.47–7.07), 0.19 (95% CI 0.13–0.26), 26.35 (95% CI 16.39–42.36), and 0.91 (95% CI 0.88–0.93), respectively. Furthermore, miR-181a, miR-223 and miR-146a demonstrated superior diagnostic efficacy with promising clinical utility in excluding and confirming LN. Additionally, findings from the subgroup analysis indicated that miRNA panels, upregulated miRNAs, and miRNAs used in the diagnosis of African patients exhibited superior diagnostic performance. Circulating microRNAs (miRNAs) show promise as noninvasive biomarkers for the early diagnosis of LN. Furthermore, miRNA panels and upregulated miRNAs exhibited improved diagnostic efficacy for LN diagnosis. However, substantiating these findings will necessitate a substantial number of prospective studies and multicenter studies in the near future.https://doi.org/10.1038/s41598-025-07860-3MiRNAsNoncoding RNAsDiagnostic biomarkersLupus nephritisLNSystemic lupus erythematous |
| spellingShingle | Ermiyas Alemayehu Alemu Gedefie Habtu Debash Abebaw Worede Zewudu Mulatie Endris Ebrahim Mulugeta Teshome Hussen Ebrahim Melaku Ashagrie Belete Circulating MiRNAs as diagnostic biomarkers of lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis Scientific Reports MiRNAs Noncoding RNAs Diagnostic biomarkers Lupus nephritis LN Systemic lupus erythematous |
| title | Circulating MiRNAs as diagnostic biomarkers of lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis |
| title_full | Circulating MiRNAs as diagnostic biomarkers of lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis |
| title_fullStr | Circulating MiRNAs as diagnostic biomarkers of lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis |
| title_full_unstemmed | Circulating MiRNAs as diagnostic biomarkers of lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis |
| title_short | Circulating MiRNAs as diagnostic biomarkers of lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis |
| title_sort | circulating mirnas as diagnostic biomarkers of lupus nephritis in patients with systemic lupus erythematosus a systematic review and meta analysis |
| topic | MiRNAs Noncoding RNAs Diagnostic biomarkers Lupus nephritis LN Systemic lupus erythematous |
| url | https://doi.org/10.1038/s41598-025-07860-3 |
| work_keys_str_mv | AT ermiyasalemayehu circulatingmirnasasdiagnosticbiomarkersoflupusnephritisinpatientswithsystemiclupuserythematosusasystematicreviewandmetaanalysis AT alemugedefie circulatingmirnasasdiagnosticbiomarkersoflupusnephritisinpatientswithsystemiclupuserythematosusasystematicreviewandmetaanalysis AT habtudebash circulatingmirnasasdiagnosticbiomarkersoflupusnephritisinpatientswithsystemiclupuserythematosusasystematicreviewandmetaanalysis AT abebawworede circulatingmirnasasdiagnosticbiomarkersoflupusnephritisinpatientswithsystemiclupuserythematosusasystematicreviewandmetaanalysis AT zewudumulatie circulatingmirnasasdiagnosticbiomarkersoflupusnephritisinpatientswithsystemiclupuserythematosusasystematicreviewandmetaanalysis AT endrisebrahim circulatingmirnasasdiagnosticbiomarkersoflupusnephritisinpatientswithsystemiclupuserythematosusasystematicreviewandmetaanalysis AT mulugetateshome circulatingmirnasasdiagnosticbiomarkersoflupusnephritisinpatientswithsystemiclupuserythematosusasystematicreviewandmetaanalysis AT hussenebrahim circulatingmirnasasdiagnosticbiomarkersoflupusnephritisinpatientswithsystemiclupuserythematosusasystematicreviewandmetaanalysis AT melakuashagriebelete circulatingmirnasasdiagnosticbiomarkersoflupusnephritisinpatientswithsystemiclupuserythematosusasystematicreviewandmetaanalysis |